Pfizer's (PFE.US) $43 billion Seagen (SGEN.US) deal wins unconditional EU approval. As it was concluded by European lawmakers, deal wouldn't raise competition concerns or higher prices for oncology drugs.
Source: xStation5
Daily Summary: A Shallow Rebound Ahead of Earnings Season
Lumentum: Demand for AI infrastructure exceeds capacity
US OPEN: Trump de-escalates, OpenAI supports Wall Street sentiment
Morning Wrap: OpenAI Revenue Concerns Weigh on Wall Street